Ichor Life Sciences, a comprehensive contract research organization (CRO), has introduced Ichor Clinical Trial Services, expanding its capabilities to cater to the needs of biotechnology and pharmaceutical clients throughout the entire drug development process, from early preclinical studies to late-stage clinical trials and FDA approval.
Ichor Clinical offers a versatile range of tailored clinical trial solutions, spanning individual service options to comprehensive CRO support. With a focus on addressing the distinctive challenges of each client, the team specializes in critical areas such as protocol design, site identification and qualification, and recruitment and retention strategies. Employing an agile, relationship-centric approach, Ichor can navigate complexities that might pose challenges for larger, more standardized CROs. This includes assisting ongoing trials facing enrollment hurdles or operational complications, steering them back towards a successful trajectory. Ichor's preclinical offerings encompass protein services, pharmacology and discovery services, and consulting services.
Heading Ichor Clinical Trial Services is Lisa Sonneborn, MA, LMHC, who previously founded and served as CEO of Clarity Clinical Research, acquired by the world's largest site management organization (SMO) in 2021. Recognized as a prominent figure in the industry, especially in clinical trial operations for Alzheimer's disease and NASH, Sonneborn has been involved in numerous industry-sponsored studies. The Ichor Clinical team brings extensive sponsor and site experience, offering a profound understanding of every facet of clinical trials.
In the current landscape of CRO industry consolidation, the comprehensive suite of services provided by Ichor is more crucial than ever. Through strategic collaborations with esteemed institutions, key opinion leaders, and regulatory authorities worldwide, Ichor has forged robust partnerships that augment the company's ability to support even the most challenging projects. This ensures Ichor's clients gain access to cutting-edge technologies, world-class facilities, and diverse patient populations.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!